Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 715739, 10 pages
http://dx.doi.org/10.1155/2010/715739
Research Article

Acanthopanax koreanum Fruit Waste Inhibits Lipopolysaccharide-Induced Production of Nitric Oxide and Prostaglandin E2 in RAW 264.7 Macrophages

1Jeju Biodiversity Research Institute (JBRI) & Jeju Hi-Tech Industry Development Institute (HiDI), Jeju 699-943, South Korea
2Sansaemi Agricultural Association, Susan-ri Aewol-eup, Jeju 697-943, South Korea
3Dermapro Skin Research Center, Dermapro Co. Ltd., Seoul 137-843, South Korea
4Department of Chemistry, Cheju National University, Ara-dong, Jeju 690-756, South Korea

Received 19 August 2009; Revised 3 December 2009; Accepted 8 January 2010

Academic Editor: Elvira Gonzalez De Mejia

Copyright © 2010 Eun-Jin Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. J. Kang, S. P. Chawla, C. Jo, J. H. Kwon, and M. W. Byun, “Studies on the development of functional powder from citrus peel,” Bioresource Technology, vol. 97, no. 4, pp. 614–620, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S.-S. Kim, J.-A. Lee, J.-Y. Kim, N. H. Lee, and C.-G. Hyun, “Citrus peel wastes as functional materials for cosmeceuticals,” Journal of Applied Biological Chemistry, vol. 51, no. 1, pp. 7–12, 2008. View at Google Scholar · View at Scopus
  3. N. T. Phuong, K. A. Lee, S. J. Jeong et al., “Capillary electrophoretic method for the determination of diterpenoid isomers in Acanthopanax species,” Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 1, pp. 56–61, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Na, W. K. Oh, Y. H. Kim et al., “Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 11, pp. 3061–3064, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. H.-S. Kang, Y.-H. Kim, C.-S. Lee, J.-J. Lee, I. Choi, and K.-H. Pyun, “Suppression of interleukin-1 and tumor necrosis factor-α production by acanthoic acid, (−)-pimara-9(11), 15-dien-19-oic acid, and its antifibrotic effects in vivo,” Cellular Immunology, vol. 170, no. 2, pp. 212–221, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-X. Nan, X.-J. Jin, L.-H. Lian et al., “A diterpenoid acanthoic acid from Acanthopanax koreanum protects against D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice,” Biological and Pharmaceutical Bulletin, vol. 31, no. 4, pp. 738–742, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-X. Nan, E.-J. Park, J. B. Nam et al., “Effect of Acanthopanax koreanum Nakai (Araliaceae) on D-galactosamine and lipopolysaccharide-induced fulminant hepatitis,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 71–77, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. H.-S. Choi, H. J. Kim, S.-G. Nam et al., “Lupane glycosides from the leaves of Acanthopanax koreanum,” Chemical and Pharmaceutical Bulletin, vol. 56, no. 11, pp. 1613–1616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Jachak, “PGE synthase inhibitors as an alternative to COX-2 inhibitors,” Current Opinion in Investigational Drugs, vol. 8, no. 5, pp. 411–415, 2007. View at Google Scholar · View at Scopus
  10. H. U. Zeilhofer and K. Brune, “Analgesic strategies beyond the inhibition of cyclooxygenases,” Trends in Pharmacological Sciences, vol. 27, no. 9, pp. 467–474, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. W. J. Yoon, S. S. Kim, T. H. Oh, N. H. Lee, and C.-G. Hyun, “Torreya nucifera essential oil inhibits skin pathogen growth and lipopolysaccharide-induced inflammatory effects,” International Journal of Pharmacology, vol. 5, no. 1, pp. 37–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. W.-J. Yoon, S.-S. Kim, T.-H. Oh, N. H. Lee, and C.-G. Hyun, “Abies koreana essential oil inhibits drug-resistant skin pathogen growth and LPS-induced inflammatory effects of murine macrophage,” Lipids, vol. 44, no. 5, pp. 471–476, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. W.-J. Yoon, S.-S. Kim, T.-H. Oh, H. L. Nam, and C.-G. Hyun, “Cryptomeria japonica essential oil inhibits the growth of drug-resistant skin pathogens and LPS-induced nitric oxide and pro-inflammatory cytokine production,” Polish Journal of Microbiology, vol. 58, no. 1, pp. 61–68, 2009. View at Google Scholar · View at Scopus
  14. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  15. T. B. Fitzpatrick, “The validity and practicality of sun-reactive skin types I through VI,” Archives of Dermatology, vol. 124, no. 6, pp. 869–871, 1988. View at Google Scholar · View at Scopus
  16. F. Casetti, W. Jung, U. Wölfle et al., “Topical application of solubilized Reseda luteola extract reduces ultraviolet B-induced inflammation in vivo,” Journal of Photochemistry and Photobiology B, vol. 96, no. 3, pp. 260–265, 2009. View at Google Scholar
  17. A. Iezzi, C. Ferri, A. Mezzetti, and F. Cipollone, “COX-2: friend or foe?” Current Pharmaceutical Design, vol. 13, no. 16, pp. 1715–1721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. K. D. Rainsford, “Anti-inflammatory drugs in the 21st century,” Sub-Cellular Biochemistry, vol. 42, pp. 3–27, 2007. View at Google Scholar · View at Scopus
  19. P. Singh and A. Mittal, “Current status of COX-2 inhibitors,” Mini-Reviews in Medicinal Chemistry, vol. 8, no. 1, pp. 73–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Y. Kim, K. S. Jung, and H. G. Jeong, “Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages,” FEBS Letters, vol. 569, no. 1–3, pp. 321–326, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. C. Mauro, F. Zazzeroni, S. Papa, C. Bubici, and G. Franzoso, “The NF-κB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-κB activity,” Methods in Molecular Biology, vol. 512, pp. 169–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. Solt and M. J. May, “The IκB kinase complex: master regulator of NF-κB signaling,” Immunologic Research, vol. 42, no. 1–3, pp. 3–18, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. X.-Y. Zhang, J.-Y. Tao, L. Zhao et al., “In vitro anti-inflammatory effects of different solution fractions of ethanol extract from Melilotus suaveolens Ledeb,” Chinese Medical Journal, vol. 120, no. 22, pp. 1992–1998, 2007. View at Google Scholar · View at Scopus
  24. L. Zhao, J.-Y. Tao, S.-L. Zhang et al., “Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb,” Inflammation, vol. 30, no. 6, pp. 213–223, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. W.-J. Yoon, Y. M. Ham, B.-S. Yoo, J.-Y. Moon, J. Koh, and C.-G. Hyun, “Oenothera laciniata inhibits lipopolysaccharide induced production of nitric oxide, prostaglandin E2, and proinflammatory cytokines in RAW264.7 macrophages,” Journal of Bioscience and Bioengineering, vol. 107, no. 4, pp. 429–438, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus